Dr. Parminder Singh, MD

Dr. Singh practices at Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona.

Dr. Singh's NPI, 1194961763, was assigned on January 1, 2009. Dr. Singh graduated from Maulana Azad Medical College in 2002. Dr. Singh holds Arizona license 46050.

Dr. Singh's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale, at 13400 East Shea Boulevard, Scottsdale, AZ 85259. The practice phone is (480) 342-4201.

Dr. Singh's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona. Dr. Singh is also affiliated with Mayo Clinic Hospital - Phoenix. The medical group on file is Mayo Clinic Arizona. Dmand AI also links Dr. Singh to 1 more medical group, named with a free account. Dr. Singh's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singh practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Singh's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Singh's licenses on file in 2 states: Arizona and Texas.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Singh treats.

CMS data shows 54,535 Medicare services from Dr. Singh across 53 procedure codes in 2024, for 946 Medicare patients. Medicare paid $1,282,054 for them. Every service was in an office.

CMS counts 946 Medicare patients who saw Dr. Singh in 2024. The largest group is 65 to 74, with 425 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 3% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Singh's median patient age at 73, with 37% women.

In 2024, Dr. Singh wrote 1,182 Medicare Part D claims for 198 patients. 71% of them were for generic drugs. CMS names the drug for 1,033 of them, across 17 drugs with 11 or more claims each, at $4,016,582 in total drug cost. In 2023, CMS named 660 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Singh for performance year 2024, reported as part of a group. Dr. Singh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Singh as offering telehealth.

Dmand AI links 67 papers to Dr. Singh, published from 2011 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Arthroscopy, Femoracetabular Impingement and Antineoplastic Combined Chemotherapy Protocols. Dr. Singh has published most often in J Hip Preserv Surg. Dr. Singh's most frequent co-authors are Alan Haruo Bryce, MD, Sumanta K. Pal, MD and Irbaz Bin Riaz, MD, MS.

Dmand AI links Dr. Singh to 1 clinical trial. Conditions studied include Ureteral Neoplasms and Urethral Neoplasms. Open Payments lists research payments to Dr. Singh that name 1 trial.

CMS Open Payments shows 142 general payments to Dr. Singh from 32 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Genentech, Inc. paid the most, $23,754. It also lists 3 research payments totaling $2,603 in 2018, naming 1 clinical trial.

Dr. Singh graduated from Maulana Azad Medical College in 2002.

Dr. Singh is in network with 4 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.